Literature DB >> 24430766

Serum homocysteine level is positively associated with chronic kidney disease in a Taiwan Chinese population.

Min-Chun Chao1, Sung-Lin Hu, Hua-Shui Hsu, Lance E Davidson, Chih-Hsueh Lin, Chia-Ing Li, Chiu-Shong Liu, Tsai-Chung Li, Cheng-Chieh Lin, Wen-Yuan Lin.   

Abstract

BACKGROUND: Both hyperhomocysteinemia and chronic kidney disease (CKD) increase risk of cardiovascular disease. In this study, we investigated the association between serum homocysteine level and CKD.
MATERIALS AND METHODS: A total of 1,581 participants were recruited from a health check-up center in a tertiary hospital in Taiwan between 2006 and 2008. Two groups were created based on serum homocysteine levels above or below 12.24 μmol/l. Estimated glomerular filtration rate (eGFR) was calculated by the Modification of Diet in Renal Disease equation; we defined CKD as an eGFR below 60 ml/min/1.73 m(2). Multivariate logistic and linear regression analyses were used to estimate the associations between serum homocysteine levels and kidney function.
RESULTS: Subjects with elevated homocysteine levels were older and had higher body mass index, blood pressures, fasting plasma glucose, total cholesterol, triglycerides, and eGFR than those with normal serum homocysteine level. Using multiple logistic regression analyses after adjustment for age, sex, lifestyle habits (smoking, alcohol consumption, and betel nut chewing) and chronic diseases (hypertension, diabetes, dyslipidemia), the odds ratio (95 % confidence interval) of having CKD was 5.76 (2.99-11.1) among subjects with elevated serum homocysteine levels compared to subjects with normal serum homocysteine levels. The significant increase in odds ratios for CKD in progressive homocysteine levels reveals a dose-response effect. After adjustment for confounders, at multiple linear regression analyses serum homocysteine level resulted significantly and negatively correlated to eGFR.
CONCLUSIONS: Elevated serum homocysteine levels appear to be closely associated with CKD. Serum homocysteine levels are negatively associated with eGFR.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24430766     DOI: 10.1007/s40620-013-0037-9

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  31 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

Review 2.  Causes of hyperhomocysteinemia in patients with chronic kidney diseases.

Authors:  Giacomo Garibotto; Antonella Sofia; Alessandro Valli; Alice Tarroni; Massimiliano Di Martino; Valeria Cappelli; Francesca Aloisi; Vanessa Procopio
Journal:  Semin Nephrol       Date:  2006-01       Impact factor: 5.299

3.  The increase of plasma homocysteine concentrations with age is partly due to the deterioration of renal function as determined by plasma cystatin C.

Authors:  L Norlund; A Grubb; G Fex; H Leksell; J E Nilsson; H Schenck; B Hultberg
Journal:  Clin Chem Lab Med       Date:  1998-03       Impact factor: 3.694

4.  Subclinical hypothyroidism is associated with elevated high-sensitive C-reactive protein among adult Taiwanese.

Authors:  Ya-Ting Yu; Chih-Te Ho; Hua-Shai Hsu; Chia-Ing Li; Lance E Davidson; Chiu-Shong Liu; Tsai-Chung Li; Chuen-Ming Shih; Cheng-Chieh Lin; Wen-Yuan Lin
Journal:  Endocrine       Date:  2013-03-07       Impact factor: 3.633

5.  Serum total homocysteine and cardiovascular disease occurrence in chronic, stable renal transplant recipients: a prospective study.

Authors:  Didier Ducloux; Gérard Motte; Bruno Challier; Roger Gibey; Jean-Marc Chalopin
Journal:  J Am Soc Nephrol       Date:  2000-01       Impact factor: 10.121

6.  Homocysteine and ischemic heart disease: results of a prospective study with implications regarding prevention.

Authors:  N J Wald; H C Watt; M R Law; D G Weir; J McPartlin; J M Scott
Journal:  Arch Intern Med       Date:  1998-04-27

7.  Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis.

Authors: 
Journal:  JAMA       Date:  2002 Oct 23-30       Impact factor: 56.272

8.  Homocysteine-lowering therapy with folic acid is effective in cardiovascular disease prevention in patients with kidney disease: a meta-analysis of randomized controlled trials.

Authors:  Xianhui Qin; Yong Huo; Di Xie; Fanfan Hou; Xiping Xu; Xiaobin Wang
Journal:  Clin Nutr       Date:  2012-12-28       Impact factor: 7.324

9.  Plasma homocysteine levels and cardiovascular mortality in patients with end-stage renal disease.

Authors:  Gherardo Buccianti; Ivano Baragetti; Fabrizia Bamonti; Silvia Furiani; Valentina Dorighet; Cristina Patrosso
Journal:  J Nephrol       Date:  2004 May-Jun       Impact factor: 3.902

10.  Betel nut chewing is strongly associated with general and central obesity in Chinese male middle-aged adults.

Authors:  Wen-Yuan Lin; F Xavier Pi-Sunyer; Chiu-Shong Liu; Tsai-Chung Li; Chia-Ing Li; Chih-Yang Huang; Cheng-Chieh Lin
Journal:  Obesity (Silver Spring)       Date:  2009-02-26       Impact factor: 5.002

View more
  12 in total

1.  Influence of renal function on the association between homocysteine level and risk of ischemic stroke.

Authors:  Yao Cheng; Fan-Zhen Kong; Xiao-Feng Dong; Qin-Rong Xu; Qian Gui; Wei Wang; Hong-Xuan Feng; Wei-Feng Luo; Zong-En Gao; Guan-Hui Wu
Journal:  Am J Transl Res       Date:  2017-10-15       Impact factor: 4.060

Review 2.  Why do young people with chronic kidney disease die early?

Authors:  Shankar Kumar; Richard Bogle; Debasish Banerjee
Journal:  World J Nephrol       Date:  2014-11-06

Review 3.  Homocysteine and hydrogen sulfide in epigenetic, metabolic and microbiota related renovascular hypertension.

Authors:  Gregory J Weber; Sathnur Pushpakumar; Suresh C Tyagi; Utpal Sen
Journal:  Pharmacol Res       Date:  2016-09-04       Impact factor: 7.658

4.  The C677T MTHFR genotypes influence the efficacy of B9 and B12 vitamins supplementation to lowering plasma total homocysteine in hemodialysis.

Authors:  Ons Achour; Sahbi Elmtaoua; Dorsaf Zellama; Asma Omezzine; Amira Moussa; Jihene Rejeb; Imene Boumaiza; Lobna Bouacida; Nabila Ben Rejeb; Abdellatif Achour; Ali Bouslama
Journal:  J Nephrol       Date:  2015-11-11       Impact factor: 3.902

5.  High Prevalence of Hyperhomocysteinemia and Its Association with Target Organ Damage in Chinese Patients with Chronic Kidney Disease.

Authors:  Zengchun Ye; Qunzi Zhang; Yan Li; Cheng Wang; Jun Zhang; Xinxin Ma; Hui Peng; Tanqi Lou
Journal:  Nutrients       Date:  2016-10-20       Impact factor: 5.717

6.  Vitamin B-6, Independent of Homocysteine, Is a Significant Factor in Relation to Inflammatory Responses for Chronic Kidney Disease and Hemodialysis Patients.

Authors:  Cheng-Hsu Chen; En-Ling Yeh; Chih-Chung Chen; Shih-Chien Huang; Yi-Chia Huang
Journal:  Biomed Res Int       Date:  2017-09-26       Impact factor: 3.411

7.  Discrimination of Chronic Kidney Disease and Diabetic Nephropathy and Analysis of Their Related Influencing Factors.

Authors:  Xiumin Liu; Yinpei Guo; Jing Wu; Nan Yao; Han Wang; Bo Li
Journal:  Diabetes Metab Syndr Obes       Date:  2020-12-30       Impact factor: 3.168

8.  Synergistic interaction of hypertension and hyperhomocysteinemia on chronic kidney disease: Findings from the National Health and Nutrition Examination Survey 1999-2006.

Authors:  Wenrui Shi; Yaping Zhou; Haoyu Wang; Yingxian Sun; Yihan Chen
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-09-16       Impact factor: 3.738

9.  No Evidence of a Causal Relationship between Plasma Homocysteine and Type 2 Diabetes: A Mendelian Randomization Study.

Authors:  Jitender Kumar; Erik Ingelsson; Lars Lind; Tove Fall
Journal:  Front Cardiovasc Med       Date:  2015-03-05

10.  Relationship between homocysteine and intraocular pressure in men and women: A population-based study.

Authors:  Haim Leibovitzh; Eytan Cohen; Amos Levi; Michal Kramer; Tzippy Shochat; Elad Goldberg; Ilan Krause
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.